Please visit our MS learning channel on Youtube, which provides hundreds of topics from our education programs, that were video-recorded and archived here: www.youtube.com/msviewsandnews -- Be empowered with MS news by registering with us: www.register.msviewsandnews.org

joomla ecommerce template -- Scroll left side of this blog for needed resources. Also, use our 'search by topic' tool, to find specific information.

Disclaimer: 'MS Views and News' DOES NOT endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.

============================================================

Tuesday, July 18, 2017

Survey: Patient-Centered Decision-Making Preferred


                                                                  
  
Click here to receive MS news via e-mail


Int J MS Care; ePub 2017 Jun 28; Cofield, et al
July 18, 2017


Nearly half (47.9%) of persons with multiple sclerosis (MS) who responded to a survey about treatment decisions most commonly preferred patient-centered decision-making, followed by shared decision-making (SDM, 42.8%). Disease-modifying therapy (DMT) use, gender, and age were associated with their decision-making preference. NARCOMS Registry participants completed the Fall 2014 Update survey, which included the Control Preferences Scale (CPS). Researchers also found:

Of 7,009 participants, 79.3% were female, 93.5% were white, and mean age (SD) was 57.6 (10.3) years; 56.7% reported a history of relapses.
SDM preference was higher for females and those taking DMTs and increased with age and disease duration.
Patient-centered decisions were most common for respondents not taking a DMT at the time of the survey and were preferred by those who had no DMT history compared with those who had previously taken a DMT.
There was no difference in SDM preference by current MS disease course after adjusting for other disease-related factors.

Citation:
Cofield SS, Thomas N, Tyry T, Fox RJ, Salter A. Shared decision-making and autonomy among US participants with multiple sclerosis in the NARCOMS Registry. [Published online ahead of print June 28, 2017]. Int J MS Care. doi:10.7224/1537-2073.2016-091.




MS Views and News is MAKING an IMPACT for those, affected by Multiple Sclerosis
MS Views and News provides beneficial Multiple Sclerosis education, information, resources and services. 
Join us, opt-in here: www.register.msviewsandnews.org 
..............................

No comments: